Finding out that the Food and Drug Administration had declined to approve Anaphylm was a blow for Aquestive Therapeutics. “Emotionally… Read more »
Food Allergy
Palforzia OIT to End: What It Means for Food Allergy Patients
When the Food and Drug Administration made Palforzia the first-ever approved food allergy treatment in 2020, allergists hailed the news… Read more »
FDA Declines Epinephrine Film’s Approval, Calls for Usability Study
The Food and Drug Administration (FDA) has declined to approve Anaphylm, the dissolving epinephrine film for treating severe allergic reactions.… Read more »
Valentine’s Candy Guide 2026: Our Top Picks of Allergy-Friendly Treats
The loveliest day of the calendar year, Valentine’s Day demands a flood of sweets, treats and sentimental declarations. We can’t… Read more »
Valentine’s Day Gift Guide 2026: Allergic Living’s Top Food-Free Finds
Flowers are fine but, if you ask us, there’s no better sight on Valentine’s Day than smiles that extend from… Read more »
FDA to Host Virtual Meeting on Food Allergy Thresholds and Labels
The U.S. Food and Drug Administration will host virtual public meetings in February on the possible use of food allergen… Read more »
Preventing Allergic Reactions by Disarming Anaphylaxis-Triggering Cells
A San Francisco-based biotech company is developing an anti-IgE therapy that prevents allergic reactions by directly disarming the immune system… Read more »
FDA Takes Steps to Improve Gluten Food Labels, Seeks Input
The U.S. Food and Drug Administration is taking steps to improve label transparency for packaged foods that contain gluten ingredients.… Read more »
Momentum Builds for New ADINA Bill to Label Allergens in Drugs
Adina Togal’s family wants 2026 to be the year that lawmakers pass federal legislation for allergen transparency on drug labels.… Read more »
Low-Dose Peanut OIT Worked Well in Study, With Fewer Reactions
Low-dose oral immunotherapy (OIT) increased tolerance to peanut in allergic children about as well as higher-dose OIT, new research finds.… Read more »